News

ONEpossible 2026 June 1-July 15. Everywhere

Jun 4, 2026

PRF is now advancing SamPro-2, a gene editing therapy that has permanently corrected the exact DNA error that causes Progeria in mouse models, toward human trials.

This is the moment everything changes. And you can be ONE to make the cure POSSIBLE!

PRF Announces Manufacturing Partnership with Forge Biologics to Advance Progeria Gene Therapy!

Mar 3, 2026

PRF Announces Manufacturing Partnership with Forge Biologics to Advance Progeria Gene Therapy!
This announcement marks a major milestone: PRF has entered into a manufacturing agreement with Forge Biologics to produce SamPro-2, its gene editing therapy in development for children and young adults with Progeria — an essential step toward clinical trials and, ultimately, the cure!

PRF’s 12th International Scientific Workshop

Nov 1, 2025

An Overwhelming Success!
Over 120 scientists met in Boston recently for one of the most engaging and exciting scientific workshops we have ever held!

Get PRF’s 2025 Newletter here!

Sep 25, 2025

Hot off the press: PRF’s 2025 Newsletter! Get the latest scoop on the Progerinin Clinical Trial, our Path to CURE PROGERIA, and so much more!

New Yorker Features Progeria Gene Editing: PRF is on the Path to CURE PROGERIA!

Aug 8, 2025

On August 11, 2025, this top-tier publication featured an in-depth article detailing PRF’s history, accomplishments, and present focus on the Gene Therapy that could bring us closer to curing Progeria. Our extraordinary journey is reaching millions more throughout the world!

New clinical trial with the drug Progerinin is officially underway

Jun 29, 2025

PRF is thrilled to announce that the first Progerinin clinical trial patient visits are complete!

ONEpossible 2025 June 1-July 15. Everywhere

May 29, 2025

Thank you so much to everyone who helped make our 2025 ONEpossible campaign a success. Together, we WILL find the cure!

PRF Co-Founders Drs. Leslie Gordon and Scott Berns speak as thought leaders at CiMUS, Spain

May 27, 2025

The Center for Research in Molecular Medicine and Chronic Diseases (CiMUS) at the University of Santiago in Spain invited PRF co-founders to share their story at a special event on Rare Disease Day 2025.

The 2024 Donor Impact Snapshot is here!

May 16, 2025

Take a look at our newly designed 2024 Donor Impact Snapshot and see the incredible progress we’re making thanks to our amazing team, which includes YOU!